Investigation of Solubility Enhancement Approaches of Ticagrelor

Investigation of Solubility Enhancement Approaches of Ticagrelor

ABSTRACT                    Ticagrelor is an orally administered antiplatelet medicine, direct-acting P2Y12-receptor antagonist. Ticagrelor binds reversibly and noncompetitively to the P2Y12 receptor at a site distinct from that of the endogenous agonist adenosine diphosphate (ADP). Inhibition o...

Full description

Bibliographic Details
Main Authors: Ihsan A. Mohammed, Mowafaq M. Ghareeb
Format: Article
Language:English
Published: College of Pharmacy University of Baghdad 2018-06-01
Series:Iraqi Journal of Pharmaceutical Sciences
Online Access:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/706

Similar Items

Similar Items